用糖覆盖的CAR T用于更甜的细胞疗法
Dachuan Dong1, Jonathan S Maltzman1,2
1Geriatric Research and Education and Clinical Center, Veterans Administration Palo Alto Health Care System, Palo Alto, CA, USA.
Science immunology
|December 5, 2025
概括
删除SPPL3 sheddase酶可以增强异性化学抗原受体 (CAR) T细胞的持久性. 这一改进对于在癌症免疫疗法中提高疗效至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 化学抗原受体 (CAR) T细胞治疗是一种有前途的癌症治疗方法.
- 同源的CAR T细胞比自身的CAR T细胞具有潜在的优势.
- 提高全基CAR T细胞的持久性对于持续的治疗效果至关重要.
研究的目的:
- 调查SPPL3散酶在调节CAR T细胞功能中的作用.
- 为了确定删除SPPL3是否可以改善全原CAR T细胞的持久性和有效性.
主要方法:
- 利用CRISPR/Cas9基因编辑来删除T细胞中的SPPL3基因.
- 生成的异种CAR T细胞缺少SPPL3.
- 在试验室和体内活体模型中评估了CAR T细胞持久性.
- 测量了CAR T细胞的增殖,细胞因子的产生和细胞毒性活性.
主要成果:
- 删除SPPL3显著增强了全原CAR T细胞的持久性.
- 缺少SPPL3的CAR T细胞表现出更好的生存率和减少对激活诱导的细胞死亡的敏感性.
- 在体内研究表明,SPPL3删除的CAR T细胞的长时间存在和增强的抗瘤活性.
结论:
- SPPL3充当全原CAR T细胞持久性的负调节者.
- 准SPPL3是一种可行的策略,可以提高全源CAR T细胞疗法的治疗潜力.
- 这一发现为设计更强大的CAR T细胞产品开辟了新的途径.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K


